Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|11|1430-1438

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.11, 2010-11, pp. : 1430-1438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylase Inhibitors In Inflammatory Disease

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 309-319

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise

By  

Current Pharmaceutical Design, Vol. 15, Iss. 34, 2009-12 ,pp. : 3940-3957

Bentham Science Publishers

Access to resources Recommend Favorite

New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 734-744

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 519-527

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 – 2013)

By Valente Sergio   Mai Antonello  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 401-415

Informa Healthcare

Access to resources Recommend Favorite